Neurotechnology startup Mave Health has raised $2.1 million (about ₹18 crore) in a seed round led by Blume Ventures, underscoring continued investor confidence in India’s fast-growing healthtech sector. The round included participation from Inuka Capital, Stanford Angels, Groww founders, Aureolis Ventures, Raymond Russell, Juhi Bhatnagar of Forj Capital and existing backer All In Capital, which increased its stake.
Technology-driven approach to mental health
Founded to transform mental healthcare in India, Mave Health develops solutions at the intersection of neuroscience, wearable devices and personalised care. The company targets common conditions such as depression through non-invasive neurotechnology integrated with expert-led wellness programmes.
Its flagship product is a brain-stimulation wearable paired with structured therapeutic programmes designed to improve mental well-being. By combining device-based interventions with continuous human support, Mave aims to shift treatment from reactive crisis management to proactive, evidence-based care.
Use of funds and growth plans
The fresh capital will be deployed to enhance product capabilities, strengthen technology infrastructure and scale reach across India. Mave also plans to bolster hiring in research, product development and clinical teams as demand for digital mental health solutions rises amid growing public awareness.
Funding history and market traction
This seed round builds on a pre-seed raise of roughly $750,000 in November 2023, reflecting steady investor interest in the startup’s trajectory. Mave has shown early traction in India’s evolving mental health market, where awareness is increasing but access to quality clinical care remains limited.
Investor sentiment and sector outlook
Blume Ventures’ lead investment aligns with its strategy of backing early-stage companies that apply technology to large, systemic problems. The firm has been actively deploying capital across healthtech, fintech and deeptech, signalling confidence in India’s innovation ecosystem.
More broadly, investors are increasingly focusing on mental health startups that leverage advanced technologies—including AI and neurotech—to deliver scalable, outcome-driven solutions. This trend mirrors rising demand driven by urban stressors, workplace pressures and heightened public discourse on mental well-being.
The road ahead
India’s mental health market is poised for growth as stigma falls and awareness rises. Startups such as Mave Health aim to bridge gaps between clinical care and accessible everyday solutions, potentially reshaping how mental health is understood and managed across the country.
